Skip to main content
    P

    Phibro Animal Health Corporation (PAHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $35.02
    -0.95 (-2.64%)

    Market Cap: $1.46B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Phibro Animal Health Corporation (PAHC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Phibro Animal Health (PAHC) to earn $3.48 per share in the fiscal year ending Jun 30, 2027, on revenue of $1.58B. Of 3 analysts, 1 rates the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Jun 30, 2027 was revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.33, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 33% of the ratings.

    RatingAnalystsShare
    Strong Buy133.3%
    Buy00.0%
    Hold266.7%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    3

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 11.5% and revenue estimates rise 3.2%.

    Fiscal year ending Jun 30, 2027
    $3.48
    EPS consensus, revenue $1.58B
    Fiscal year ending Jun 30, 2028
    $3.88
    EPS consensus, revenue $1.63B
    Next report
    Feb 2, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Jun 30, 2027$3.48$3.47 to $3.503$1.58B$1.57B to $1.59B3
    Jun 30, 2028$3.88$3.75 to $4.063$1.63B$1.62B to $1.65B3

    Quarterly Estimates

    Across the 3 quarters below, the EPS consensus is lowest for the quarter ending Mar 31, 2027, at $0.87, and highest for the quarter ending Dec 31, 2026, at $0.94.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.94$0.91 to $0.972$402.00M$402.00M to $402.00M1
    Mar 31, 2027$0.87$0.84 to $0.892$397.00M$397.00M to $397.00M1
    Jun 30, 2027$0.91$0.86 to $0.964$411.06M$394.94M to $423.15M3

    Estimate Revisions

    Across the 4 periods below, the last 30 days brought 4 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Jun 30, 202710
    Fiscal year ending Jun 30, 202810
    Quarter ending Dec 31, 202610
    Quarter ending Mar 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Jun 30, 2027 has risen 4.2% from $3.34.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Jun 30, 2027$3.48$3.50$3.50$3.50$3.34+4.1%
    Fiscal year ending Jun 30, 2028$3.88$3.85$3.84$3.85$3.69+5.3%
    Quarter ending Dec 31, 2026$0.94$0.94$0.99$0.97$0.91+3.0%
    Quarter ending Mar 31, 2027$0.87$0.88$0.85$0.86$0.80+8.4%

    Frequently Asked Questions About PAHC

    What is the PAHC stock forecast?

    Consensus analyst estimates put Phibro Animal Health's EPS at $3.48 for the fiscal year ending Jun 30, 2027, on revenue of $1.58B. The consensus rating from 3 analysts is Buy.

    How do analysts rate PAHC stock?

    Of 3 analysts covering Phibro Animal Health, 1 rates it Strong Buy, 0 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from PAHC next year?

    For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is $3.48, with estimates from $3.47 to $3.50 from 3 analysts. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is $3.88, with estimates from $3.75 to $4.06 from 3 analysts.

    What revenue do analysts expect from Phibro Animal Health next year?

    For the fiscal year ending Jun 30, 2027, the consensus revenue estimate is $1.58B, with estimates from $1.57B to $1.59B. For the fiscal year ending Jun 30, 2028, the consensus revenue estimate is $1.63B, with estimates from $1.62B to $1.65B.

    How many analysts cover PAHC?

    3 analysts rate Phibro Animal Health stock, and 3 analysts estimate its EPS for the fiscal year ending Jun 30, 2027.